A random version of principal component analysis in data clustering by Palese, Luigi Leonardo
A random version of principal component analysis in data
clustering
Luigi Leonardo Palese1,*,
1 University of Bari ”Aldo Moro”, Department of Basic Medical Sciences,
Neurosciences and Sense Organs (SMBNOS), Bari, 70124, Italy
* luigileonardo.palese@uniba.it
Abstract
Principal component analysis (PCA) is a widespread technique for data analysis that
relies on the covariance-correlation matrix of the analyzed data. However to properly
work with high-dimensional data, PCA poses severe mathematical constraints on the
minimum number of different replicates or samples that must be included in the
analysis. Here we show that a modified algorithm works not only on well dimensioned
datasets, but also on degenerated ones.
Introduction
Science today is surrounded by large amounts of data. These are produced by
techniques and instruments able to measure a huge number of variables on a large
number of samples, they are deposited in an increasing number of online databases that
grow exponentially, and also modern numerical simulations can produce very large and
high-dimensional outputs. The challenge of the growing size of data concerns all
sciences, but the field in which we have seen the most spectacular growth is probably
that of life sciences, where the advancement of genomics, proteomics and
high-throughput technologies has produced an overwhelming amount of data, more and
more often freely available to all researchers. Beside the large number of samples, these
data are big also because they are high-dimensional: this means that each sample, or
instance, of a typical dataset contains a large number of degree of freedom. Such
high-dimensionality makes visualization and exploration of samples and datasets very
difficult. To overcome these limitations, a series of techniques have been developed that
help researchers in visualization, exploration and mining of large data. [44]
Among the various algorithms that reduce the dimensionality of data, while
retaining the important information, one of the most successful is principal component
analysis (PCA). [36] PCA has been reinvented several times, but it has been developed
in its modern form by Pearson and Hotelling. [8, 19,31] How PCA works is recalled in
the Methods section, but here it is important to note that, in its classical
implementation, PCA relies on the covariance (or also correlation) matrix of the
analyzed data. This is actually a point often overlooked by end-users, but it should be
stressed that the number of samples needed to accurately estimate the
covariance/correlation matrix of a system containing n degree of freedom should be
(much) larger than n. Otherwise the covariance/correlation matrix will be full of
spurious correlations, as well as rank deficient from a mathematical point of view if the
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number of samples is less than n. However here we will show that what is important for
the functioning of the method it is not a particular covariance/correlation matrix, but
rather the symmetry that characterizes this type of matrices.
Results and Discussion
We developed the method in order to calculate the PCA of a set of protein
crystallographic structures. Proteins are structurally and dynamically complex
objects. [13, 27] Because molecular dynamics (MD) is actually at a level of accuracy [10]
that permits to predict experimentally observables, [6] it is nowadays a standard tool for
the dynamical characterization of proteins. In the analysis of MD trajectories PCA is of
widespread use: [23] the high-dimensional large number of different molecular
conformations that constitute the output of a MD experiment is an ideal dataset for
PCA. [7] On the other hand, the number of protein structures reported in the Protein
Data Bank [2] (PDB) is collectively large, but there are few structures of a single
protein. Although it is possible to find dozens or even hundreds of versions of a single
protein in the PDB, the number of available structures is incomparably smaller than the
number of degree of freedom of a protein. So while PCA can be used in the analysis of
the thousands of conformations obtained from MD simulations, in its classical
implementation PCA can not be used in the analysis of the experimental structures as
the low number of different conformations reported in the PDB does not allow an
accurate calculation of the covariance matrix. To perform a structural analysis similar
to the PCA we choose to analyze the human serum albumin (HSA) available structures
in the PDB. HSA, [12] the most abundant protein in plasma, is a monomeric
multi-domain molecule. HSA is a non-glycosylated, all-α protein chain of 65 kDa, with
a globular heart-shaped conformation consisting of three homologous domains (I-III).
Each domain is composed by two subdomains (A and B). It is an important transport
protein with different binding sites able to accommodate a number of chemically
different ligands. HSA represents the main carrier for fatty acids (there are seven
binding sites for fatty acids, labeled as FA1 to FA7), and it is a depot and carrier for
exogenous compounds (mainly, but not exclusively at the Sudlow’s sites I and II), thus
affecting the pharmacokinetics of many drugs.
Among the available structures, we selected 58 structure for the analysis (see
Methods for selection criteria). After structural alignment, the α-carbon atom
Cartesian coordinates were extracted and arranged in a data matrix in which each row
represented a single HSA structure. Thus the data matrix was composed of 58 rows and
1695 columns (565 α-carbon atoms were finally included in the analysis; see the
Methods section). This is clearly a degenerated dataset, as it is impossible to obtain the
true correlation matrix of a multivariate system with 1695 degree of freedom by using
only 58 samples. If we calculate the correlation matrix, this will be, at best, only a rank
deficient approximation of the true one in which a large number of false correlations
must be expected. While it is true that, using a careful error handling (and silencing)
program, or also using algorithms that estimate the principal components without ever
computing the covariance matrix, [38] it is generally possible to calculate the first
principal components, the classical PCA is not calculable on this dataset.
It should be considered that what really we are interested in is not the identification
of the axes that describe the greatest variance of the data (axes which do not have a
particular a priori meaning), but instead an orthogonal linear transformation of data
that could be useful in exploratory data analysis. We can relax the request that the
correlation-covariance matrix (the true or the approximated one) is needed for such
transformation: it is possible that what is important in PCA as clustering tool may not
be the use of a particular matrix, but instead of a matrix belonging to a particular
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symmetry class. The bases for such an hypothesis are rooted in the fact that good
models for the covariance matrices for the protein configurations obtained from
MD [28–30] are a class of symmetric random matrices. [11] Moreover, the consequences
of the Johnson-Lindenstrauss lemma, [22] and the fact that in the Pearson original
view [8, 31] of PCA which is important is the subspace and not the axes as such, furnish
us a further justification. Thus we applied to the albumin dataset a variant of the PCA
algorithm, in which a square symmetric random matrix was used, instead of the
correlation-covariance one (this matrix was obviously of dimension of 1695). We will
refer to this algorithm as random component analysis (RCA). The detailed algorithm is
described in the Methods section, and an easily customizable implementation is
reported in Supplementary Information section.
The results of this analysis are reported in Figure 1. As can be easily appreciated by
inspecting the figure, RCA leads to two well defined clusters of structures, and what is
more interesting is that one cluster contains all and only the HSA molecules with bound
fatty acid, the other one only structures without fatty acid. These cluster are
Figure 1. Random component analysis of the HSA structures. The Figure
reports a random component analysis on the HSA structures contained in the dataset
described in the text. The HSA structures with bound fatty acids are reported as solid
(black) circles, whereas the structures without bound fatty acids are reported as void
(white) circles. The algorithm clearly permits to differentiate two clusters of structures in
the dataset, and the discriminant is the presence of absence, respectively, of bound fatty
acids. Two similar cluster of structures have been obtained in all the random component
analysis calculations carried out on the HSA dataset (see Supplementary Information).
reproducible (see Supplementary Figure 1) and are similar to those obtained by
different protocols (see Methods and Supplementary Figure 2). It worth noting that a
large number of structural and functional works on HSA lead to the conclusion that two
structures, possibly related to the presence of fatty acids, are discernible for this
protein. [1, 12] Our RCA analysis permits to go further, as it clearly demonstrates that
the only discriminant for such structural switch in the whole dataset is the presence or
absence of bound fatty acid.
While RCA has been developed for degenerated datasets (that means datasets that
are characterized by a larger number of degree of freedom respect to the number of
samples that can be analyzed) we tested it also on well sized datasets. These were
retrieved the from the UCI (University of California at Irvine, School of Information
and Computer Science) Machine Learning Repository (Lichman, M.,
http://archive.ics.uci.edu/ml). The results of PCA and RCA on the classical Iris
dataset are reported in Figure 2. It can be stated that RCA is at least not inferior to
PCA in clustering purposes, and the results are reproducible, as reported in
Supplementary Figure 3. Similar results have been obtained with the Wine dataset,
which are reported in the Supplementary Figure 4.
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Figure 2. The Iris dataset. Principal component analysis (left) and random compo-
nent analysis (right) of the Iris dataset are reported. The Iris dataset is a simple but
classical benchmark for the clustering algorithms. This dataset contains 150 entries, 50
for each of the species Iris virginica (black), Iris setosa (gray) and Iris versicolor (white).
Both algorithms easily differentiate the Iris setosa cluster, whereas the other species can
be only partially discriminated by the algorithms of this class. The full set of random
component analysis carried out on the Iris dataset shows similar clustering results and it
is reported in Supplementary Information.
Conclusions
The algorithm proposed in this communication is easy to implement, conceptually
simple and numerically robust. It is another example of useful application of random
matrix theory, [11, 28–30] whose pervasiveness is even more evident in a large number of
fields. This work demonstrates that what is important for clustering efficiency of PCA
is not the exact form of the covariance-correlation matrix, but instead simply its
symmetry, as in our RCA algorithm. The fact that good and informative clustering can
be achieved by random projection is nowadays an emerging concept that, beside
practical applications, could have far reaching implications also from a conceptual point
of view. Finally, this work suggests that an excessive confidence on correlations (which
are often spurious) and on large covariance should be avoided, if a simple random
matrix could well surrogate them in cluster generation.
Methods
HSA database construction
In order to build up a suitably large dataset of structures we searched in the Protein
Data Bank [2] (www.rcsb.org) for the albumin structures, with the constraints of specie
(human), single protein type in the structure, and resolution of 3.30 A˚ or better. After
this initial screening, because some N- and C-terminal residues are often not present in
the deposited structure, and in order to include the largest possible number of
structures as complete as possible, the ones starting after the SER 5 and ending before
ALA 569 were excluded from the database. Finally, the structures containing a number
of α-carbon atoms different of 565 were also excluded. The final dataset contained 58
structures [3–5,9, 14–18,33–35,40,42,43,46–52] which are reported in the
Supplementary Table 1.
A pdb file for each of these structures has been written in VMD [20] (from SER 5 to
ALA 569); these structures were aligned using MultiSeq [37] and the pdb files were
updated to the new coordinates. The same software was used to calculate the distance
trees (RMSD and Qh style). [25, 39] The obtained tree are reported as Supplementary
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Figure 2 (see also the Supplementary Table 2).
To obtain the dataset in a matrix form, the pdb files were loaded in VMD and the
α-carbon atom coordinates were extracted and written in a text file such that each row
described a structure, by a Tcl (www.tcl.tk) script. Curly brackets in the raw text file
were eliminated by vim scripting (www.vim.org), so as to obtain the data matrix in a
readable file format by the numerical analysis software.
The PCA and RCA algorithms
PCA was based on the eigenvector decomposition of the correlation
matrix. [7, 8, 28,29,36,41,44] After the centroid subtraction, the covariance matrix of
the dataset matrix described above was obtained as
Cij = 〈(xi − 〈xi〉)(xj − 〈xj〉)〉
where 〈. . .〉 represents the average over all the conformations in the dataset. The
correlation matrix was calculated from this matrix as
Pij =
Cij√
CiiCjj
with obvious meaning of symbols. This square symmetric matrix was diagonalized
RTPR = Λ
using standard numerical routines (see below), where R is an orthonormal
transformation matrix, the superscript T means transposition and Λ is a diagonal
matrix whose elements are the eigenvalues. The empirical matrix was projected onto
the eigenvectors to give the principal components.
The RCA was performed exactly as the PCA, except for the fact that the square
symmetric correlation matrix was replaced by a random symmetric matrix, obtained as
M =
G+GT
2
where G was a normal distributed random square matrix. So this algorithm could be
conceived as a version of classical PCA with relaxed constraints respect to the matrix to
be used in calculating the new orthonormal reference system, where only the matrix
symmetry is preserved.
Software implementation and code availability
The PCA and RCA algorithms were implemented in the Python language
(www.python.org) in an IPython notebook. [32] The NumPy numerical software
library [45] was used, which is part of the Scipy [26] software package. The Pandas [24]
and Matplotlib [21] packages were used to import the Iris and Wine datasets and to
obtain the all graphical outputs, respectively (both packages were obtained from Scipy;
www.scipy.org). The implementation of these algorithms is reported in Supplementary
Information in Python format. Two versions of the RCA algorithm are reported: the
first one requires the dataset and the dimension of the dummy correlation matrix as
arguments, while the second requires as arguments the dataset and the random matrix
that will be used for the calculation of the orthogonal projection system. This last
function could be useful if one would save a particularly interesting matrix for further
analysis. These files are easily customizable; as it is provided, the software requires
(very) few seconds for the download and analysis of the proposed datasets (the HSA
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dataset described above, the Iris and Wine datasets) on an Intel Core i7 machine or a
Xeon equipped workstation, both running Ubuntu 14.04 LTS. Very large datasets (as in
the case of MD outputs; not shown) could require up to (also several) minutes to be
analyzed. Because the RCA algorithm performs a random projection it is preferable to
carry out multiple runs of it. In a small percentage of cases (no more than 5% - 10% of
the tests used for this work) the algorithm does not get a projection that separates the
samples in different clusters, and this is the only drawback of the simple implementation
of the RCA algorithm here described.
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Supplementary Figure 1. HSA random component analysis. The figure reports
9 consecutive application runs of the random component analysis algorithm on the HSA
dataset described in the main text. The HSA structures with bound fatty acids are
reported as black circles, whereas the HSA structures without fatty acids (either ligand
free or with chemically different ligands) are reported as open (white) circles. It is
evident that the two class of HSA structures are in different clusters.
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Supplementary Figure 2. Tree clustering of HSA dataset. The Qh (left) and
RMSD (right) trees have been obtained with the MultiSeq program as described in
the main text. The numbers correspond to the protein PDB entries as reported in the
Supplementary Table 1 (see below). Both algorithms recognize two clusters (cluster A
and B in Supplementary Table 2): cluster A contains the HSA structures without bound
fatty acids, while cluster B contains HSA molecules with bound fatty acid.
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Supplementary Figure 3. Random component analysis of Iris dataset. The
figure reports 9 consecutive application runs of the random component analysis algorithm
on the Iris dataset. The Iris virginica specie is reported in black, the Iris setosa in gray
and Iris versicolor in white. As in the case of PCA, the algorithm easily differentiate
the Iris setosa cluster, whereas the other species can be only partially discriminated by
the algorithms of this class (linear classifiers).
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Supplementary Figure 4. The wine dataset. The dataset was retrieved from the
UCI repository (see text). It contains three different cultivars, indicated as 1, 2 and 3 in
the on line repository and here reported as gray, white and black circles. The top-left
panel reports the principal component analysis of this dataset, while all other panels
report different runs of random component analysis. The cultivars, particularly those
indicated as 2 and 3, partially overlap with both algorithms.
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# PDB Ligands Res A˚
1 1BM0 N/A 2,5
2 1E78 N/A 2,6
3 1E7A 2,6-BIS(1-METHYLETHYL)PHENOL (PROPOFOL) 2,2
4 1E7C MYRISTIC ACID; 2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE 2,4
5 1E7E DECANOIC ACID 2,5
6 1E7F LAURIC ACID 2,43
7 1E7G MYRISTIC ACID 2,5
8 1E7H PALMITIC ACID 2,43
9 1E7I STEARIC ACID 2,7
10 1GNI OLEIC ACID 2,4
11 1GNJ ARACHIDONIC ACID 2,6
12 1H9Z R-WARFARIN; MYRISTIC ACID 2,5
13 1HA2 S-WARFARIN; MYRISTIC ACID 2,5
14 1HK4 3,5,3’,5’-TETRAIODO-L-THYRONINE; MYRISTIC ACID 2,4
15 1HK5 3,5,3’,5’-TETRAIODO-L-THYRONINE; MYRISTIC ACID 2,7
16 1N5U PROTOPORPHYRIN IX CONTAINING FE (HEME); MYRISTIC ACID 1,9
17 1O9X PROTOPORPHYRIN IX CONTAINING FE (HEME); MYRISTIC ACID 3,2
18 1UOR N/A 2,8
19 2BX8 AZAPROPAZONE 2,7
20 2BXB 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE- 3,5-DIONE (OXYPHENBUTAZONE) 3,2
21 2BXC 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE 3,1
22 2BXD R-WARFARIN 3,05
23 2BXF 7-CHLORO-1-METHYL-5-PHENYL-1,3-DIHYDRO-2H- 1,4-BENZODIAZEPIN-2-ONE 2,95
24 2BXG 2-(4-ISOBUTYLPHENYL)PROPIONIC ACID (IBUPROFEN) 2,7
25 2BXI AZAPROPAZONE; MYRISTIC ACID 2,5
26 2BXK INDOMETHACIN; AZAPROPAZONE; MYRISTIC ACID 2,4
27 2BXL 2-HYDROXY-3,5-DIIODO-BENZOIC ACID; MYRISTIC ACID 2,6
28 2BXM INDOMETHACIN; MYRISTIC ACID 2,5
29 2BXN 3-[5-[(3-CARBOXY-2,4,6-TRIIODO-PHENYL)CARBAMOYL]PENTANOYLAMINO]- 2,4,6-TRIIODO-BENZOIC ACID; MYRISTIC ACID 2,65
30 2BXO 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE- 3,5-DIONE (OXYPHENBUTAZONE); MYRISTIC ACID 2,6
31 2BXP 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE; MYRISTIC ACID 2,3
32 2BXQ INDOMETHACIN; 4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE; MYRISTIC ACID 2,6
33 2I2Z MYRISTIC ACID; 2-HYDROXYBENZOIC ACID (SALICYLIC ACID) 2,7
34 2I30 MYRISTIC ACID; 2-HYDROXYBENZOIC ACID (SALICYLIC ACID) 2,9
35 2XSI DANSYL-L-GLUTAMATE; MYRISTIC ACID 2,7
36 2XVV DANSYL-L-ASPARAGINE; MYRISTIC ACID 2,4
37 2XVW DANSYL-L-ARGININE; MYRISTIC ACID 2,65
38 3B9L 3’-AZIDO-3’-DEOXYTHYMIDINE (AZIDOTHYMIDINE); MYRISTIC ACID 2,6
39 3B9M 3’-AZIDO-3’-DEOXYTHYMIDINE (AZIDOTHYMIDINE); MYRISTIC ACID; 2-HYDROXYBENZOIC ACID (SALICYLIC ACID) 2,7
40 3CX9 (2S)-3-[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY- 2-HYDROXYPROPYL HEXADECANOATE; MYRISTIC ACID 2,8
41 3JRY SULFATE ION 2,3
42 3LU6 [(1R,2R)-2-[(5-FLUORO-1H-INDOL-2-YL)CARBONYL]AMINO- 2,3-DIHYDRO-1H-INDEN-1-YL]ACETIC ACID 2,7
43 3LU7 4-[(1R,2R)-2-[(5-FLUORO-1H-INDOL-2-YL)CARBONYL]AMINO- 2,3-DIHYDRO-1H-INDEN-1-YL]BUTANOIC ACID; PHOSPHATE ION 2,8
44 3SQJ MYRISTIC ACID 2,05
45 3UIV MYRISTIC ACID; (3S,5S,7S)-TRICYCLO[3.3.1.1 3,7 ]DECAN-1- AMINE (AMANTADINE) 2,2
46 4BKE PALMITIC ACID 2,35
47 4G03 N/A 2,22
48 4G04 N/A 2,3
49 4IW2 ALPHA-D-GLUCOSE; D-GLUCOSE IN LINEAR FORM; PHOSPHATE ION 2,41
50 4K2C N/A 3,23
51 4L8U (2S)-2-[1-AMINO-8-(HYDROXYMETHYL)-9-OXO-9,11- DIHYDROINDOLIZINO[1,2-B]QUINOLIN-7-YL]-2- HYDROXYBUTANOIC ACID; MYRISTIC ACID 2,01
52 4L9K (2S)-2-HYDROXY-2-[8-(HYDROXYMETHYL)-9-OXO- 9,11-DIHYDROINDOLIZINO[1,2-B]QUINOLIN-7-YL]BUTANOIC ACID 2,4
53 4L9Q TENIPOSIDE 2,7
54 4LA0 R-BICALUTAMIDE 2,4
55 4LB2 IDARUBICIN 2,8
56 4LB9 ETOPOSIDE; MYRISTIC ACID 2,7
57 4Z69 2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID (DICLOFENAC); PALMITIC ACID; PENTADECANOIC ACID 2,19
58 5IFO MYRISTIC ACID; RUTHENIUM ION 3,2
Supplementary Table 1. Ligands, resolution and literature references of the HSA dataset.
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# PDB bound fatty acids Qh tree RMSD Tree RCA cluster
1 1BM0 no A A A
2 1E78 no A A A
3 1E7A no A A A
4 1E7C yes B B B
5 1E7E yes B B B
6 1E7F yes B B B
7 1E7G yes B B B
8 1E7H yes B B B
9 1E7I yes B B B
10 1GNI yes B B B
11 1GNJ yes B B B
12 1H9Z yes B B B
13 1HA2 yes B B B
14 1HK4 yes B B B
15 1HK5 yes B B B
16 1N5U yes B B B
17 1O9X yes B B B
18 1UOR no A A A
19 2BX8 no A A A
20 2BXB no A A A
21 2BXC no A A A
22 2BXD no A A A
23 2BXF no A A A
24 2BXG no A A A
25 2BXI yes B B B
26 2BXK yes B B B
27 2BXL yes B B B
28 2BXM yes B B B
29 2BXN yes B B B
30 2BXO yes B B B
31 2BXP yes B B B
32 2BXQ yes B B B
33 2I2Z yes B B B
34 2I30 yes B B B
35 2XSI yes B B B
36 2XVV yes B B B
37 2XVW yes B B B
38 3B9L yes B B B
39 3B9M yes B B B
40 3CX9 yes B B B
41 3JRY no A A A
42 3LU6 no A A A
43 3LU7 no A A A
44 3SQJ yes B B B
45 3UIV yes B B B
46 4BKE yes B B B
47 4G03 no A A A
48 4G04 no A A A
49 4IW2 no A A A
50 4K2C no A A A
51 4L8U yes B B B
52 4L9K no A A A
53 4L9Q no A A A
54 4LA0 no A A A
55 4LB2 no A A A
56 4LB9 yes B B B
57 4Z69 yes B B B
58 5IFO yes B B B
Supplementary Table 2. HSA dataset clusters.
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Numerics
The Python functions below perform the principal component analysis (PCA) and
random component analysis (RCA).
#import pandas as pd #uncomment if needed
import numpy as np
import matplotlib.pyplot as plt
import pylab as pl
#from scipy import stats #uncomment if needed
def GOE(N):
"""
Returns a random N x N matrix of the GOE ensemble. !
"""
m = np.random.standard_normal((N, N))
m = (m + np.transpose(m))/2
return m
#This function implements the classical PCA
def PCA(data):
"""Returns the dataset projected onto the principal basis system"""
data -= data.mean(axis=0)
R_matrix = np.corrcoef(data.T)
eig_vals, eig_vecs = np.linalg.eig(R_matrix)
#sort eigenvalues and eigenvectors in decreasing order
index = np.argsort(eig_vals)[::-1]
eig_vecs = eig_vecs[:, index]
#
#performs a test on the lengh of the eigenvectors
for eigvector in eig_vecs:
np.testing.assert_array_almost_equal(1.0, np.linalg.norm(eigvector))
#if the test is not passed, Numpy returns an error message!
return np.dot(eig_vecs.T, data.T).T, eig_vals
#This function implements the random component analysis
def RCA(data, N):
"""Returns the dataset projected onto a random basis system"""
data -= data.mean(axis=0)
R_matrix = GOE(N)
eig_vals, eig_vecs = np.linalg.eig(R_matrix)
#sort eigenvalues and eigenvectors in decreasing order
index = np.argsort(eig_vals)[::-1]
eig_vecs = eig_vecs[:, index]
#
#performs a test on the lengh of the eigenvectors
for eigvector in eig_vecs:
np.testing.assert_array_almost_equal(1.0, np.linalg.norm(eigvector))
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#if the test is not passed, Numpy returns an error message!
return np.dot(eig_vecs.T, data.T).T, eig_vals
def RCA1(data, M):
"""Returns the dataset projected onto a random basis system.
The random matrix should be determined externally.
"""
data -= data.mean(axis=0)
R_matrix = M
eig_vals, eig_vecs = np.linalg.eig(R_matrix)
#sort eigenvalues and eigenvectors in decreasing order
index = np.argsort(eig_vals)[::-1]
eig_vecs = eig_vecs[:, index]
#
#performs a test on the lengh of the eigenvectors
for eigvector in eig_vecs:
np.testing.assert_array_almost_equal(1.0, np.linalg.norm(eigvector))
#if the test is not passed, Numpy returns an error message!
return np.dot(eig_vecs.T, data.T).T, eig_vals
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